Evolution of the Average Target: CME Group Inc.

Evolution of the Average Target - CME Group Inc.

Evolution of the Target Price: CME Group Inc.

Evolution of the Target Price - CME Group Inc.

Changes in Analyst Recommendations: CME Group Inc.

5cff9a78d0659bac0e5a.s9PrcUlqBxTA2GAfvKTuY0_yBCjDubvueS-C4MzU4Pg.25iMMgAJPzntsQNR3_uZDweAMWmIwdndEGfjrbiuprv_sNhBcRlBIoe2JQ~4175170c2508ad91542d8584f09a06aa
10-23 Goldman Sachs Adjusts Price Target on CME Group to $271 From $254 MT
10-22 Wells Fargo Adjusts Price Target on CME Group to $333 From $315 MT
10-22 Piper Sandler Adjusts Price Target on CME Group to $330 From $295 MT
10-22 JPMorgan Upgrades CME Group to Overweight From Neutral, $367 Price Target MT
10-22 Deutsche Bank Adjusts CME Group Price Target to $284 From $277, Maintains Hold Rating MT
10-22 Morgan Stanley Adjusts Price Target on CME Group to $359 From $337 MT
10-22 Barclays Adjusts Price Target on CME Group to $321 From $281 MT
10-21 Raymond James Adjusts Price Target on CME to $330 From $320 MT
10-21 Autonomous Research Adjusts CME Group Price Target to $311 From $297 MT
10-14 Wells Fargo Adjusts Price Target on CME Group to $315 From $301 MT
10-12 Deutsche Bank Adjusts Price Target on CME Group to $277 From $270 MT
10-09 Morgan Stanley Adjusts Price Target on CME Group to $337 From $330 MT
10-08 Rothschild & Co Redburn Adjusts Price Target on CME to $330 From $317 MT
10-07 Jefferies Adjusts CME Group Price Target to $328 From $286 MT
10-07 Barclays Adjusts Price Target on CME Group to $281 From $270 MT
10-05 UBS Adjusts Price Target on CME Group to $270 From $260, Keeps Neutral Rating MT
10-05 TD Cowen Adjusts Price Target on CME Group to $300 From $292, Keeps Buy Rating MT
10-02 Raymond James Adjusts CME Group Price Target to $320 From $330, Maintains Outperform Rating MT
10-02 Goldman Sachs Adjusts Price Target on CME Group to $254 From $252, Keeps Sell Rating MT
10-02 BofA Securities Adjusts CME Group PT to $217 From $230, Maintains Underperform Rating MT
09-10 Bank of America Turns More Bullish on Cboe, CME, ICE Despite Perps Threat MT
09-10 Rothschild & Co Redburn Adjusts Price Target on CME Group to $317 From $309, Keeps Buy Rating MT
08-19 Deutsche Bank Downgrades CME Group to Hold From Buy, Adjusts Price Target to $270 From $286 MT
08-10 Rothschild & Co Redburn Adjusts PT on CME Group to $309 From $306, Keeps Buy Rating MT
07-23 CME Group Broadening Long-Term Growth Opportunity With Multiple Emerging Vectors, Morgan Stanley Says MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.37%
+15.23%
-1.92%
+24.24%
+35.47%
+11.4%
+4.81%
-4.26%
-3.41%
Average +9.44%
Weighted average by Cap. +11.41%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
305.71USD
Average target price
316.00USD
Spread / Average Target
+3.37%
High Price Target
367.00USD
Spread / Highest target
+20.05%
Low Price Target
227.00USD
Spread / Lowest Target
-25.75%

Analyst Consensus Detail

Analyst consensus - CME Group Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - CME Group Inc.
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CME Group Inc.
  1. Stock Market
  2. Stocks
  3. CME Stock
  4. Consensus CME Group Inc.